Skip Navigation LinksHome > October 2013 - Volume 32 - Issue 10 > Delayed Epithelial Closure After PRK Associated With Topical...
Cornea:
doi: 10.1097/ICO.0b013e31829e1e8c
Clinical Science

Delayed Epithelial Closure After PRK Associated With Topical Besifloxacin Use

Talamo, Jonathan H. MD; Hatch, Kathryn M. MD; Woodcock, Emily C. BS

Collapse Box

Abstract

Purpose:

To report the observation of prolonged reepithelialization after photorefractive keratectomy (PRK) associated with the use of besifloxacin 0.6% (Besivance; Bausch & Lomb, Rochester, NY) underneath bandage contact lenses (BCLs) placed during surgery.

Methods:

An office-based private practice and retrospective chart review. The healing parameters examined included epithelial healing time, haze formation, discomfort, and visual recovery of 4 patients (7 eyes) treated with besifloxacin 0.6% under BCLs placed after the PRK was performed.

Results:

All the eyes had delayed epithelial closure (mean, 8.8 days; range 5–13 days). All the patients experienced a delayed visual recovery and significant pain after the surgery, and 2 of 4 patients experienced recurrent corneal erosions for weeks to months after they underwent the PRK. All but 1 eye developed corneal haze persisting for 1 year or more after the surgery. Only 1 eye among the 7 eyes treated with besifloxacin 0.6% under the BCL had 20/20 or better uncorrected visual acuity 3 months postoperatively.

Conclusions:

All the patients treated with besifloxacin 0.6% on the stromal bed exhibited significant problems with corneal epithelial healing and delayed visual recovery. We caution the use of besifloxacin 0.6% underneath a BCL during a PRK or other ocular surface surgeries requiring corneal epithelial debridement.

Copyright © 2013 by Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.